Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study.

已完结 10 由何曼慈发布于 2026/6/11 18:09:08

DOI:10.1016/S2352-3026(22)00284-8
作者：Thomas Martin, Yi Lin, Mounzer Agha, Adam D Cohen, Myo Htut, A Keith Stewart, Parameswaran Hari, Jesus G Berdeja, Saad Z Usmani, Tzu-Min Yeh, Yunsi Ol
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/S2352-3026(22)00284-8

Elsevier

Abstract：Background: CARTITUDE-1 is a phase 1b-2 study evaluating ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T cell therapy with two B-cell maturation antigen-targeting single

应助信息

1天前

Book学术机器人

0d50ca31e4f011ef8e0c34735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/6/11 18:09:09 Book学术AI机器人已找到文献并上传

2026/6/11 18:09:08 Book学术AI机器人收到请求，开始寻找文献

2026/6/11 18:09:08 已向机器人发送请求

1天前

何曼慈发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Machine learning applications in the diagnostic work-up of varicocele